STOCKHOLDERS’ EQUITY |
12 Months Ended |
|---|---|
Dec. 31, 2025 | |
| Equity [Abstract] | |
| STOCKHOLDERS’ EQUITY | NOTE 6–STOCKHOLDERS’ EQUITY
The Company was formed with one class of no-par value common stock and was authorized to issue common shares, as amended. Voting rights are not cumulative and, therefore, the holders of more than 50% of the common stock could, if they chose to do so, elect all of the directors of the Company.
During January 2025, the Company issued shares of restricted stock to Sellavir consultants valued at $222,625 on dates of issuance. The shares are subject to a 12-month vesting period from the date of issuance. The Company expensed $, included in general and administrative expenses, during the year ended December 31, 2025. The remaining $ will be recorded during January 2026.
|